Abstract
P-glycoprotein is an ATP-binding-cassette transporter that pumps many structurally unrelated drugs out of cells through an ATP-dependent mechanism. As a result, multidrug-resistant cells that overexpress P-glycoprotein have reduced intracellular steady-state levels of a variety of chemotherapeutic agents. In addition, increased cytosolic pH has been a frequent finding in multidrug-resistant cells that express P-glycoprotein, and it has been proposed that this consequence of P-glycoprotein expression may contribute to the lower intracellular levels of chemotherapeutic agents. In these studies, we measured intracellular pH and the rate of acid extrusion in response to an acid load in two cells with very different levels of P-glycoprotein expression: V79 parental cells and LZ-8 multidrug resistant cells. Compared to the wild-type V79 cells, LZ-8 cells have a lower intracellular pH and a slower recovery of intracellular pH after an acid load. The data also show that LZ-8 cells have reduced ability to extrude acid, probably due to a decrease in Na+/H+ exchanger activity. The alterations in intracellular pH and acid extrusion in LZ-8 cells are reversed by 24-h exposure to the multidrug-resistance modulator verapamil. The lower intracellular pH in LZ-8 indicates that intracellular alkalinization is not necessary for multidrug resistance. The reversal by verapamil of the decreased acid-extrusion suggests that P-glycoprotein can affect other membrane transport mechanism.
Keywords: MDR1, Na+/H+ exchanger, verapamil, multidrug resistance, Adriamycin, intracellular pH regulation
Introduction
Overexpression of P-glycoprotein (Pgp, MDR1, ABCB1), a 170-kD plasma membrane glycoprotein, produces multidrug resistance in tumor cells and mammalian cells in culture [1,2]. Multidrug resistance is characterized by resistance to the cytotoxic effects of a wide variety of chemically unrelated drugs that have different mechanisms of action [1-3]. Multidrug-resistant cells that overexpress Pgp have reduced intracellular steady-state levels of a variety of chemotherapeutic agents, which results primarily from pumping of the drugs out of the cells by Pgp [1-3].
Increased intracellular pH (pHi) has been a frequent finding in Pgp-expressing multidrug-resistant cells [4-12], and it has been proposed that this alteration is a consequence of Pgp expression that contributes to the reduced intra-cellular levels of chemotherapeutic agents [4,7,9,10,12]. Alterations in pHi in multidrug-resistant cells are potentially important because most Pgp substrates are liposoluble, aromatic, and positively charged at physiologic extracellular pH [13,14]. It is likely that the concentration of uncharged (lipophilic) moiety of the drug is similar on both sides of the plasma membrane; the pHi level would then determine the concentration of the protonated (slowly-permeant) moiety, and thus its total intracellular concentration.
Although alterations of pHi can result from changes in the activity of pHi regulatory mechanisms, there are very few studies of these mechanisms in Pgp-expressing cells. In two studies an increase in the Na+-dependent rate of pHi recovery was reported [5,11]. However, the intracellular buffering power was not determined and hence it is possible that the increase in pHi recovery rate is the result of reduced cyto-solic H+ buffering, and not increased efflux of H+ equivalents (JH). In view of the possible role of pHi in multidrug resistance and the absence of measurements of JH during pHi recovery from an acid load, we decided to further study pHi and its regulation in two Chinese hamster fibroblast cell lines with very different Pgp levels.
Materials and methods
Cells and Western blots
Experiments were performed on subconfluent monolayers of wild-type (V79) and multidrug-resistant (LZ-8) Chinese hamster lung fibroblasts. Cell lines were grown in F10 medium supplemented with 10% FBS, with the addition of Adriamycin in the case of LZ-8 cells. Adriamycin, a fluorescent drug, was removed from the culture medium 1 day prior to the experiments. Both cell lines express Pgp, but its level at the plasma membrane of LZ-8 cells is >20-fold that of V79 cells [15]. This translates in increased resistance to Adriamycin, vinblastine and colchicine (∼3,000-, 200-, and 300-fold, respectively, compared to V79 cells), and faster rate of efflux of Adriamycin and rhodamine 123 [15-18]. Additional details on these cell lines have been published [15-17]. Inmunoblots were performed on crude membranes subjected to 7% SDS-PAGE using the anti-P-glycoprotein antibody C219 (Covance, Princeton, NJ). Detection was by enhanced chemiluminescence (ECL, GE Healthcare).
Experimental setup and solutions
Cells were plated in 60-160 mm-thick, 25-mm-diameter round coverslips in a solution (control solution) of the following composition: 25 mM HCO3-, 115 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 1.5 mM Na phosphate, and 8.3 mM glucose, equilibrated with 95% O2/5% CO2, pH 7.42-7.43. The Hepes-buffered solution used to determine intrinsic buffering power (βi) contained: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2 8.3 mM glucose, and 10 mM Hepes/NaOH, pH 7.42-7.43 (air equilibrated). When used, NH4Cl partially replaced NaCl mol-by-mol. Nigericin was used at a concentration of 5μM, from a 10 mM stock in ethanol. Amiloride (1 mM) was dissolved directly in the experimental solutions and verapamil (25 μM) was added from a 5 mM stock in water.
pHi measurements
pHi was measured using the pH-sensitive fluorescent probe 2’7’-biscarboxyethly-5(6) carboxyfluorescein (BCECF), essentially as described [16]. Cells were loaded with the pH-sensitive probe by a 60-min incubation with 10 μM tetraacetoxymethyl ester of BCECF (BCECF-AM), at 37°C. After loading, the cells were immediately used or kept for up to 1 h before use in Petri dishes with control solution without BCECF-AM. The degree of BCECF loading was not statistically different in V79 and LZ-8 cells, and the BCECF leakage from both cell lines was similar (∼0.3%/min). The coverslips with the BCECF-loaded cells were mounted on a chamber (Leiden microincubator, Medical Systems Corp., Greenvalle, NY) placed on the stage of an inverted microscope (Nikon Diaphot, Nikon, Tokyo). The cells were superfused by gravity at a rate of 15-25 ml/min, at 37°C, using a system based on glass condensers. The pH and temperature of the solution bathing the cells was indistinguishable from that of the control solution at 37°C, indicating no significant heat or CO2 losses.
The pHi was estimated from the BCECF fluorescence emission ratio (measured at 535 nm) at excitation wavelengths of 495 and 440 nm (F495/F440). Excitation light originated from a 150-W Xenon lamp was split (beam splitter, Oriel Instruments) into two parallel pathways after passing through a heat filter (Oriel Instruments, Stratford, CT). Each of the parallel pathways had a band-pass filter (440DF10 or 495DF10, Omega Optical Inc., Brattleboro, VT) and a computer-controlled shutter (Vincent Associates, Rochester, NY) in series. The shutters opened sequentially for 100 ms during each measurement to minimize photobleaching. Light from the two pathways was merged and directed to the epifluorescence attachment (Nikon) of the inverted microscope using a bifurcated optic fiber (Oriel Instruments). Illumination was restricted to the cells under study using a field diaphragm. The excitation light reflected by a dichroic mirror (515DRLP, Omega Optical Inc) was focused onto the cells with a 40X, 1.3 NA oil-immersion objective (Nikon 78820). Emitted light collected by the same objective, passed through the dichroic mirror, and then a band-pass filter (535DF35, Omega Optical Inc). A lens (CCTV adapter with 1X relay lens, Nikon) was used to defocus the fluorescent light which was measured with an end-on photomultiplier tube (77346, Oriel Instruments). Currents generated by the photomultiplier were converted to voltages with a current preamplifier (70710, Oriel Instruments) and input into an A/D converter (TL1-DMA interface, Molecular Devices, Sunnyvale, CA). Data acquisition and shutters control were done with “in-house” software, and data analysis with SigmaPlot (Systat software, San Jose, CA).
The average fluorescence of 100-150 cells was collected, but in preliminary experiments we found similar results from single-cell recordings. Autofluorescence was less than 1% of the signal in BCECF-loaded cells and no attempt was made to correct for it. Under the loading conditions employed, there was no evidence of BCECF compartmentalization, from confocal fluorescence images, and by the lack of differences in the F495/F440 emission ratio in different spots of single cells. In addition, 50 mM digitonin released >95% of BCECF from V79 and LZ -8 cells. Calculations of pHi were based on the nigericin technique [19], using high-K+ solutions containing: 10 mM KCl, 1 mM MgCl2 2 mM CaCl2, 8.3 mM glucose, 20 mM NaCl, 90 mM potassium gluconate, and 10 mM Hepes, titrated to various pH values. At the end of each experiment, cells were exposed sequentially to two calibration solutions of pH 7.0 and 7.3, respectively. The F495/F440 nm emission ratio in these solutions was normalized to the value obtained for the same pH in the average calibration curve (Figure 2B, see Results), and all ratios in the experiment were converted to pH using the calibration curve.
Figure 2.
Intracellular calibration of the pH-sensitive probe BCECF. (A) Typical record showing the changes in BCECF fluorescence emission in response to changes in extracellular pH (pHo, indicated at the top bar) in high-K+ solutions in the presence of 5 μM nigericin. The trace displays the ratio of BCECF emission at excitation wavelengths of 495 and 440 (F495/F440) as a function of time. The trace shown is from LZ-8 cells. (B) Average F495/F440 changes from V79 and LZ-8 pooled data (n = 10 for each cell type). Data from the two cell lines were statistically undistinguishable.
Net fluxes of acid equivalents (JH)
These were calculated from the total intracellular buffering power (βt) and the rates of change in pHi according to: JH = (ΔpHi/Δt) βt. The cells bT is the sum of the intrinsic buffering power in the nominal absence of HCO3/CO2 and the HCO3-/CO2 buffering power (βt = βi + βBic; βBic = 2.3 α pCO2 10pHi-pK [20], where α is the CO2 solubility coefficient. Determination of βi was done from the pHi changes produced by addition of NH4Cl at constant extracellular pH, with pHi regulatory mechanisms blocked (Hepes-buffered solution with 1 mM amiloride, see Results). The βi calculations are based on the assumptions that: a) NH3 permeability is high enough to make steady -state [NH3] equal inside and outside the cells, b) NH3 permeability >>> NH4+ permeability, and c) the apparent pK (pKa = 8.9) of the NH3/NH4+ system at 37°C is the same inside and outside the cells. Then, βi is calculated from βi = Δ[NH4+i /ΔpHi, where intracellular [NH4+] ([NH4+]i) is calculated from [NH4+]i = [NH3]i · 10pk-pHi [20].
Data presentation and statistics
Data are presented as means ± SEM. Statistical comparisons were done by Student t-tests for paired or unpaired data as appropriate, and differences were considered significant when P < 0.05.
Results
Figure 1 shows that the level of Pgp expression in LZ-8 cells is much higher than that in the parental V79 cells. Calibration of BCECF inside V79 and LZ-8 cells was performed by the technique of Thomas et al. [19]. Figure 2A illustrates the changes in the fluorescence ratio, F495/F440, as a function of extracellular pH in LZ-8 cells. The cells were bathed with Hepes-buffered solution, which was replaced with high-K+ calibration solutions of the pH indicated in the top bar, in the presence of the K+/H+ exchanger ionophore nigericin. The first solution substitution produced a change in F495/F440 that reached a stable value after ∼1.5 min, but subsequent solution changes caused much faster alterations. The slow initial change probably reflects the time required for incorporation of enough nigericin into the plasma membrane to rapidly equilibrate extracellular and intracellular pH. The responses of V79 and LZ-8 cells were indistinguishable, and the pooled data were used to calculate the pKa of BCECF inside the cells (Figure 2B).
Figure 1.
Expression of P-glycoprotein in membranes of V79 and LZ-8 cells. Immunoblot of crude membranes from V79 (150 μg) and LZ-8 (12.5 μg) cells probed with the anti-Pgp antibody C219. The arrow on the right points to Pgp and the molecular weight marker positions in kDa are indicated on the left side.
As shown in Figure 3, the calculated steady-state pHi in HCO3-/CO2-buffered solution was lower in LZ-8 than in V79 cells. Exposure to 25 μM of verapamil for 1 h did not affect pHi in either cell line (Figure 3). However, 24-h exposure to verapamil (in the culture medium and all experimental solutions) elevated LZ-8 cells pHi to a value statistically indistinguishable from that in V79 cells (Figure 3). Verapamil is a modulator of multidrug resistance that blocks transport of other Pgp substrates; at 25 μM, it increases the cytotoxic effects of Adriamycin and vinblastine, and rapidly reduces the unidirectional efflux of rhodamine 123 [18,21,22].
Figure 3.
Basal intracellular pH (pHi) and effects of verapamil. Data are means ± SEM from V79 (n = 16) and LZ-8 (n = 17) cells in the absence of verapamil, and exposed to verapamil for 1 h (V79, n = 6; LZ-8, n = 6), or 24 h (V79, n = 10; LZ-8, n = 8). The asterisks denote P < 0.05 compared to V79 cells in the absence of verapamil. Verapamil was used at a concentration of 25 μM.
The efficiency of the cells to recover from an acid load was studied following the changes in pHi produced by transient exposure to 25 mM NH4Cl (Figure 4) [16,20]. Upon addition of NH4Cl, pHi increases due to rapid NH3 entry which buffers H+, generating NH4+ and raising pHi. After the peak alkalinization, there is a slow pHi decrease (“plateau acidification”) attributed to influx of H+ equivalents in the form of NH4+, which produces the acid load. Upon NH4Cl removal, pHi falls rapidly to a minimum below control because of the rapid NH3 efflux and the intracellular trapping of H+ from the dissociation of NH4+. Then, pHi returns to control values by the action of membrane transport mechanisms that extrude H+ equivalents. As shown in Figure 4, pHi recovery is faster in V79 (Figure 4A) than in LZ-8 cells (Figure 4B).
Figure 4.
Recovery of pHi from an acid load. Response of V79 (A) and LZ-8 (B) cells to an acid load elicited by transient exposure to 25 mM NH4Cl.
Although the basal pHi was lower in LZ-8 cells, pHi was similar in both cell lines immediately after removal of NH4Cl (V79 = 6.62 ± 0.11, n = 20; LZ-8 = 6.52 ± 0.13, n = 16, P > 0.05) indicating that the acid loading procedure was more efficient in V79 cells. This is expressed by the slower acidification during exposure to NH4Cl in LZ-8 cells (Figure 4; V79 ApHi = 0.40 ± 0.06, n = 20; ΔpHi LZ-8 = 0.21 ± 0.05, n = 16; P < 0.05). This alteration was reversed by 24-h exposure of LZ-8 cells to 10 μM verapamil (data not shown).
The reduced pHi recovery from an acid load in LZ-8 cells can result from a decrease in the activity of pHi regulatory mechanisms (i.e., real fall in JH), and/or to an elevation of the intracellular buffering power (same JH, with slower pHi change due to increased buffering). To distinguish between these possibilities, βi was measured as detailed in “Materials and methods”, and exemplified in Figure 5A. The cell shown was acid-loaded by exposure to 50 mM NH4Cl in Hepes-buffered solution with 1 mM amiloride added at the time of NH4Cl removal. At 1 mM, amiloride completely blocks pHi regulation (note that pHi is the same at the beginning and end of the record). The pHi changes were measured upon exposure to several NH4Cl concentrations, and βi was calculated from the changes in pHi and [NH4+] (see “Materials and methods”). The values of βi obtained in V79 and LZ-8 did not differ significantly, and the pooled data are shown in Figure 5B. Figure 5B also shows βBic and βT, calculated as described in “Materials and methods” [20]. From the analysis of the data in Figure 3 and Figure 5, under control conditions, βT is significantly higher in V79 than in LZ-8 cells, and HCO3/CO2 is the main buffer system in these cells (∼75%), whereas it contributes less (∼50%) to βT in LZ-8 cells. The reason for these differences is the lower control pHi in LZ-8 compared to V79 cells since βT and its dependency on pHi were similar in both cells lines. Since the minimum pHi after NH4Cl removal (see above) and βT (Figure 5B) were the same in V79 and LZ-8 cells, the slower pHi recovery in LZ-8 cells (Figure 5A) can be unambiguously attributed to a decreased activity of pHi recovery mechanisms. Figure 6 shows average pHi recovery data from V79 and LZ-8 cells (Figure 6A), as well as the calculated initial rates of JH (Figure 6B). Since the rates of pHi recovery follow single exponential rises to the control pHi, and βT changes between pHi of 6.5 and 7.2 are relatively minor, it follows that JH is faster in V79 than in LZ-8 cells in the whole pHi range studied.
Figure 5.
Intracellular buffering power. (A) Typical record showing the changes in pHi in response to changes in bath solution [NH4Cl] (indicated in the top bar, in mM) in cells superfused with Hepes-buffered solution in the presence of 1 mM amiloride. Under these conditions intracellular pHi regulation is abolished and the pHi changes can be used to calculate the intrinsic buffering power (βi, see Materials and methods for details). The trace shown was obtained in V79 cells. (B) Average βi from V79 (n = 9) and LZ-8 (n = 10) pooled data. Data from the two cell lines were statistically indistinguishable, and are presented as open circles (means ± SEM). SEMs smaller than the symbols are not shown. The solid line labeled βi is the fit of the data to: βi = 2.3 · K · [IB] · [H+]/(K + [H+])2 [see 20] where K and [IB] are the intracellular buffers dissociation constant and concentration, respectively. The estimates of [IB] and pK were 56 mM and 6.41, respectively. The βBic line is the HCO3/CO2 buffering (see Materials and methods) and βT is the sum of βi and βT.
Figure 6.
Efflux of H+ equivalents after an acid load. (A) Average traces of pHi recovery after an acid load (see Figure 4). The records shown in red are averages from n = 8 experiments in each of the cell lines. The black lines are single-exponential fits to the data that yielded rate constants of 1.05 and 0.73 min-1 for the V79 and LZ-8 data, respectively. (B) Average efflux of H+ equivalents (JH) after the acid load. The JH values were calculated from the ΔpHi/Δtime data and the intracellular buffering power βT), and are shown as means ± SEM. Data are from V79 (n = 20) and LZ-8 (n = 13) cells in the absence of verapamil, and exposed to verapamil for 1 h (V79, n = 6; LZ-8, n = 6), or 24 h (V79, n = 6; LZ-8, n = 7). The asterisks denote P < 0.05 compared to V79 cells in the absence of verapamil. Verapamil was used at a concentration of 25 μM.
Exposure to verapamil for 1 h did not affect pHi recovery from the acid load, but 24-hour exposure to verapamil enhanced the ability of LZ-8 cells to recover from an acid load to values comparable to those of V79 cells (Figure 6B). The effect of verapamil on βt was small or nil, as indicated by similar changes in pHi upon addition and removal of NH4Cl in V79 and LZ-8 cells treated with verapamil, compared to changes in the absence of the drug (data not shown).
Discussion
The results of the present experiments show that, compared to the wild-type V79 cells, the highly multidrug-resistant LZ-8 cells have a lower pHi, a slower acidification during exposure of NH4Cl, and a slower pHi recovery upon removal of NH4Cl.
The reduced acidification during exposure to NH4Cl in LZ-8 vs. V79 cells can be the result of a slower rate of NH4+ influx, and/or a decrease in activity of pHi regulatory mechanisms operative during the intracellular alkalinization produced by NH3 entry. Experiments to discriminate among these possibilities were not performed. However, a reduced NH4+ seems likely because NH4+ influx into the cells may occur via the Na+/ H+ exchanger and K+ channels. We observed decreased activity of the exchanger in the present studies, and reductions in cell membrane voltage, which will decrease NH4+ electrochemical driving force for its permeation through K+ channels, have been found in multidrug-resistant cells [12,23].
The lower pHi in LZ-8 compared to V79 cells confirms that intracellular alkalinization is not necessary for multidrug resistance [16,24,25]. Although it is possible that V79 cells, which have low levels of Pgp expression [15,16], have an increased pHi with respect to cells without Pgp, verapamil had no effect on their pHi, whereas it elevated LZ-8 cells pHi. Additional support for the lack of cause-effect relationship between cell alkalinization and Pgp expression comes from other studies. Although pHi was found elevated in a number of cells expressing Pgp [4-12], there are also reports of absence of pHi differences between drug-sensitive and multidrug-resistant cells [16,24,25].
The response of multidrug-resistant cells to acid loads has been studied before [5,11,24], but intracellular buffering power was not measured in any of those studies, leaving open the possibility that the observed increases in the rates of pHi recovery [5,11] were due to alterations in βT, and not to the activity of pHi regulatory mechanisms. Our findings of similar βT in V79 and LZ-8 cells, and reduced rates of pHi recovery in the latter prove that LZ-8 cells have reduced ability to extrude H+ equivalents. Although we did not study the specific pHi regulatory mechanisms in detail, the absence of pHi regulation upon acid load in Hepes-buffered solutions containing 1 mM amiloride (see Figure 5A) suggests that Na+/H+ exchange is a major pHi regulatory mechanism in V79 and LZ-8 cells. Therefore, a decrease in the Na+/H+ exchanger activity in the multidrug-resistant LZ-8 cells seems very likely. Since increased activity of Na+/H+ exchange has been reported in multidrug-resistant cells [5] and we found the opposite in LZ-8 cells, alterations in pHi regulation may occur in different ways in different multidrug-resistant cells.
Exposure to verapamil for 1 h or less reversed the pHi alkalinization observed in some but not all cell lines [5,6]. Our results show absence of reversing effect by 1-h exposure to verapamil on pHi and its recovery from an acid load, but reversal upon 24-h exposure. If cells have endogenous Pgp substrates that modulate membrane transporters, the time-dependent effects of verapamil could result from differences in the relative rates of production and efflux of those substrates. The poly-specificity of Pgp and the identification of endogenous substrates [3,14] support this idea. Many alterations have been found in Pgp-expressing multidrug-resistant cells in addition to increased drug efflux and pHi changes. These include alterations in ion transport, intracellular Ca2+ regulation, lipid composition, membrane trafficking, and cell-membrane voltage [11,12,23,26-33]. The mechanism of these varied alterations can be explained in part by changes in the levels of endogenous Pgp substrates, which may have different, and even opposite effects depending on the cell type. It remains to be explored whether the secondary alterations in Pgp-expressing cells modify multidrug resistance (e.g., effect of pHi on Pgp function).
Acknowledgement
We want to thank Dessa Glass for technical help. This work was supported in part by the Cancer Prevention & Research Institute of Texas Individual Investigator Award RP101073.
Abbreviations
- BCECF
2’7’-biscarboxyethly-5(6) carboxyfluorescein
- βBic
HCO3-/CO2 buffering power
- βi
intrinsic buffering power
- βT
total buffering power
- Pgp
P-glycoprotein
- pHi
intracellular pH
References
- [1].Goda K, Bacsó Z, Szabó G. Multidrug resistance through the spectacle of P-glycoprotein. Curr Cancer Drug Targets. 2009;9:281–97. doi: 10.2174/156800909788166493. [DOI] [PubMed] [Google Scholar]
- [2].Seeger MA, van Veen HW. Molecular basis of multidrug transport by ABC transporters. Biochim Biophys Acta. 2009;1794:725–37. doi: 10.1016/j.bbapap.2008.12.004. [DOI] [PubMed] [Google Scholar]
- [3].Gutmann DA, Ward A, Urbatsch IL, Chang G, van Veen HW. Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. Trends Biochem Sci. 2010;35:36–42. doi: 10.1016/j.tibs.2009.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Keizer HG, Joenje H. Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil. J Natl Cancer Inst. 1989;81:706–9. doi: 10.1093/jnci/81.9.706. [DOI] [PubMed] [Google Scholar]
- [5].Boscoboinik D, Gupta RS, Epand RM. Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells. Br J Cancer. 1990;61:568–72. doi: 10.1038/bjc.1990.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Thiebaut F, Currier SJ, Whitaker J, Haugland RP, Gottesman MM, Pastan I, Willingham MC. Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem. 1990;38:685–90. doi: 10.1177/38.5.1692055. [DOI] [PubMed] [Google Scholar]
- [7].Roepe PD. Analysis of steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry. 1992;31:12555–125. doi: 10.1021/bi00165a003. [DOI] [PubMed] [Google Scholar]
- [8].Luz JG, Wei LY, Basu S, Roepe PD. Transfection of mu MDR 1 inhibits Na(+)-independent CI-/HCO3- exchange in Chinese hamster ovary cells. Biochemistry. 1994;33:7239–49. doi: 10.1021/bi00189a028. [DOI] [PubMed] [Google Scholar]
- [9].Simon S, Roy D, Schindler M. Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci USA. 1994;91:1128–32. doi: 10.1073/pnas.91.3.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Simon SM, Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA. 1994;91:3497–3504. doi: 10.1073/pnas.91.9.3497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Wei LY, Hoffman MM, Roepe PD. Altered pHi regulation in 3T3/CFTR clones and their chemotherapeutic drug-selected derivatives. Am J Physiol. 1997;272:C1642–53. doi: 10.1152/ajpcell.1997.272.5.C1642. [DOI] [PubMed] [Google Scholar]
- [12].Roepe PD. What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance? Curr Pharm Des. 2000;6:241–60. doi: 10.2174/1381612003401163. [DOI] [PubMed] [Google Scholar]
- [13].Pearce HL, Winter MA, Beck WT. Structural characteristics of compounds that modulate P -glycoprotein-associated multidrug resistance. Adv Enzyme Regul. 1990;30:357–73. doi: 10.1016/0065-2571(90)90026-x. [DOI] [PubMed] [Google Scholar]
- [14].Wang RB, Kuo CL, Lien LL, Lien EJ. Structure-activity relationship: analyses of P-glycoprotein substrates and inhibitors. J Clin Pharm Ther. 2003;28:203–28. doi: 10.1046/j.1365-2710.2003.00487.x. [DOI] [PubMed] [Google Scholar]
- [15].Sognier MA, Zhang Y, Eberle RL, Belli JA. Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines. Biochem Pharmacol. 1992;44:1859–68. doi: 10.1016/0006-2952(92)90082-t. [DOI] [PubMed] [Google Scholar]
- [16].Altenberg GA, Young G, Horton JK, Glass D, Belli JA, Reuss L. Changes in intra-or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc Natl Acad Sci USA. 1993;90:9735–38. doi: 10.1073/pnas.90.20.9735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Howell N, Belli TA, Zaczkiewicz LT, Belli JA. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes. Cancer Res. 1984;44:4023–9. [PubMed] [Google Scholar]
- [18].Altenberg GA, Vanoye CG, Han ES, Deitmer JW, Reuss L. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein. J Biol Chem. 1994;269:7145–9. [PubMed] [Google Scholar]
- [19].Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectro-scopic probes generated in situ. Biochemistry. 1979;81:2210–8. doi: 10.1021/bi00578a012. [DOI] [PubMed] [Google Scholar]
- [20].Roos A, Boron WF. Intracellular pH. Physiol Rev. 1981;61:296–434. doi: 10.1152/physrev.1981.61.2.296. [DOI] [PubMed] [Google Scholar]
- [21].Ford JM. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur J Cancer. 1996;32A:991–1001. doi: 10.1016/0959-8049(96)00047-0. [DOI] [PubMed] [Google Scholar]
- [22].Horton JK, Thimmaiah KN, Altenberg GA, Castro AF, Germain GS, Gowda GK, Houghton PJ. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein. Mol Pharmacol. 1997;52:948–57. doi: 10.1124/mol.52.6.948. [DOI] [PubMed] [Google Scholar]
- [23].Vayuvegula B, Slater L, Meador J, Gupta S. Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia. Cancer Chemother Pharmacol. 1988;22:163–8. doi: 10.1007/BF00257315. [DOI] [PubMed] [Google Scholar]
- [24].Litman T, Pedersen SF, KramhØft B, Skovsgaard T, Hoffmann EK. pH regulation in sensitive and multidrug resistant Ehrlich ascites tumor cells. Cell Physiol Biochem. 1998;8:138–50. doi: 10.1159/000016277. [DOI] [PubMed] [Google Scholar]
- [25].Frezard F, Garnier-Suillerot A. Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and - sensitive K562 cells. Biochim Biophys Acta. 1991;1091:29–35. doi: 10.1016/0167-4889(91)90217-l. [DOI] [PubMed] [Google Scholar]
- [26].Sehested M, Skovsgaard T, van Deurs B, Winther-Nielsen H. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br J Cancer. 1987;56:747–51. doi: 10.1038/bjc.1987.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Yamashita N, Hamada H, Tsuruo T, Ogata E. Enhancement of voltage gated Na+ channel current associated with multidrug resistance in human leukemia cells. Cancer Res. 1987;47:3736–41. [PubMed] [Google Scholar]
- [28].Fritz F, Howard EM, Hoffman MM, Roepe PD. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein. Biochemistry. 1999;38:4214–26. doi: 10.1021/bi981929n. [DOI] [PubMed] [Google Scholar]
- [29].Vanoye CG, Castro AF, Pourcher T, Reuss L, Altenberg GA. Phosphorylation of P-glycoprotein by PKA and PKC modulates swelling-activated Cl- currents. Am J Physiol. 1999;276:C370–8. doi: 10.1152/ajpcell.1999.276.2.C370. [DOI] [PubMed] [Google Scholar]
- [30].Porcelli AM, Scotlandi K, Strammiello R, Gislimberti G, Baldini N, Rugolo M. Intracellular pH regulation in U-2 OS human osteosarcoma cells transfected with P-glycoprotein. Biochim Biophys Acta. 2002;1542:125–38. doi: 10.1016/s0167-4889(01)00173-2. [DOI] [PubMed] [Google Scholar]
- [31].Mizutani T, Masuda M, Nakai E, Furumiya K, Togawa H, Nakamura Y, Kawai Y, Nakahira K, Shinkai S, Takahashi K. Genuine functions of P-glycoprotein (ABCB1) Curr Drug Metab. 2008;9:167–74. doi: 10.2174/138920008783571756. [DOI] [PubMed] [Google Scholar]
- [32].Sulová Z, Seres M, Barancík M, Gibalová L, Uhrík B, Poleková L, Breier A. Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis? Gen Physiol Biophys. 2009;28:F89–95. [PubMed] [Google Scholar]
- [33].Poulsen KA, Andersen EC, Hansen CF, Klausen TK, Hougaard C, Lambert IH, Hoffmann EK. Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels. Am J Physiol Cell Physiol. 2010;298:C14–25. doi: 10.1152/ajpcell.00654.2008. [DOI] [PubMed] [Google Scholar]






